We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02947347
Recruitment Status : Active, not recruiting
First Posted : October 27, 2016
Last Update Posted : September 9, 2022
Sponsor:
Information provided by (Responsible Party):
Pharmacyclics LLC.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2026
Estimated Study Completion Date : June 2026